ATE47961T1 - Impfstoffe, verfahren zu deren herstellung und verfahren zur anregung der antikoerperherstellung. - Google Patents

Impfstoffe, verfahren zu deren herstellung und verfahren zur anregung der antikoerperherstellung.

Info

Publication number
ATE47961T1
ATE47961T1 AT82301181T AT82301181T ATE47961T1 AT E47961 T1 ATE47961 T1 AT E47961T1 AT 82301181 T AT82301181 T AT 82301181T AT 82301181 T AT82301181 T AT 82301181T AT E47961 T1 ATE47961 T1 AT E47961T1
Authority
AT
Austria
Prior art keywords
genes
manufacture
vaccines
encouraging
processes
Prior art date
Application number
AT82301181T
Other languages
English (en)
Inventor
Walter Southwick Dallas
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Application granted granted Critical
Publication of ATE47961T1 publication Critical patent/ATE47961T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT82301181T 1981-03-09 1982-03-08 Impfstoffe, verfahren zu deren herstellung und verfahren zur anregung der antikoerperherstellung. ATE47961T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24159481A 1981-03-09 1981-03-09
EP82301181A EP0060129B1 (de) 1981-03-09 1982-03-08 Impfstoffe, Verfahren zu deren Herstellung und Verfahren zur Anregung der Antikörperherstellung

Publications (1)

Publication Number Publication Date
ATE47961T1 true ATE47961T1 (de) 1989-12-15

Family

ID=22911341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82301181T ATE47961T1 (de) 1981-03-09 1982-03-08 Impfstoffe, verfahren zu deren herstellung und verfahren zur anregung der antikoerperherstellung.

Country Status (9)

Country Link
EP (1) EP0060129B1 (de)
JP (1) JP2554611B2 (de)
AT (1) ATE47961T1 (de)
AU (1) AU559550B2 (de)
CA (1) CA1201076A (de)
DE (1) DE3280019D1 (de)
DK (1) DK172670B1 (de)
NZ (1) NZ199866A (de)
WO (1) WO1982003088A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US5097020A (en) * 1983-07-05 1992-03-17 The University Of Rochester Immunogenic conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US5360897A (en) * 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
JPS58502181A (ja) * 1982-01-18 1983-12-22 サンド・アクチエンゲゼルシヤフト 新規プラスミドと細菌株並びにその製造法
JPS58146596A (ja) * 1982-02-25 1983-09-01 Takeda Chem Ind Ltd 組換えｄｎａ、それで形質転換させた微生物およびそれらの用途
GB8314645D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Bivalent vaccines
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
AU589114B2 (en) * 1984-02-01 1989-10-05 Enterovax Limited Genetically engineered bacteria useful as a vaccine
AU619908B2 (en) * 1984-02-01 1992-02-06 Enterovax Research Pty. Ltd. Bacterial strains
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
ES8705033A1 (es) * 1984-12-04 1987-04-16 Biotech Australia Pty Ltd Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
JP2660511B2 (ja) * 1985-05-15 1997-10-08 バイオテクノロジ−・オ−ストラリア・ピ−テイ−ワイ・リミテツド 経口ワクチン
US6103243A (en) * 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
FR2605017B1 (fr) * 1986-10-13 1989-10-06 Solvay Microorganismes comportant des pili comme proteines porteuses, pili isoles a partir de ces microorganismes et procede d'excretion de peptides ou de proteines a l'aide de ces pili.
DE3783425T2 (de) * 1986-10-13 1993-05-13 Solvay Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
DE3712890A1 (de) * 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
US5162226A (en) * 1987-08-24 1992-11-10 University Of Tennessee Research Corp. (U.T.R.C.) Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US5124153A (en) * 1987-08-24 1992-06-23 University Of Tennessee Research Corp. Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
US5079165A (en) * 1988-06-29 1992-01-07 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit in S. typhi
ATE218797T1 (de) * 1988-09-06 2002-06-15 Univ Washington Orale-immunisierung durch verwendung von transgenen pflanzen
AU2793797A (en) * 1997-05-21 1998-12-11 Dae Woong Pharmaceutical Co., Ltd. A recombinant microorganism expressing an antigenic protein, adhesin
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
PL377387A1 (pl) 2002-11-25 2006-02-06 Den Kgl.Veterinaer- Og Landbohojskole Polimorfizymy u świń i sposoby ich wykrywania
ES2531971T3 (es) 2004-02-03 2015-03-23 Prevtec Microbia Inc. Uso de bacterias vivas para fomentar el crecimiento en animales
EP2167664B1 (de) * 2007-07-02 2012-01-25 Gotovax AB Hybridoperon zur expression von kolonisationsfaktorantigenen enterotoxigener escherichia coli

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294835A (de) * 1962-07-19 1900-01-01
US3907987A (en) * 1972-05-25 1975-09-23 Canadian Patents Dev Enteric disease vaccine
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2530275A1 (de) * 1975-07-07 1977-01-27 Max Planck Gesellschaft Salmonella-coli-hybride, verfahren zu deren herstellung und vermehrung und apathogener lebend-impfstoff gegen salmonellosen
SE7811458L (sv) * 1977-11-08 1979-05-09 Genentech Inc Forfarande och medel for polypeptidbildning via mikrober
FR2442271A1 (fr) * 1978-11-27 1980-06-20 Pasteur Institut Vecteur permettant l'insertion d'un gene procaryote ou eucaryote, et l'excretion de la proteine exprimee
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype

Also Published As

Publication number Publication date
AU559550B2 (en) 1987-03-12
EP0060129B1 (de) 1989-11-15
AU8331082A (en) 1982-09-28
DE3280019D1 (en) 1989-12-21
CA1201076A (en) 1986-02-25
EP0060129A2 (de) 1982-09-15
JPS57171926A (en) 1982-10-22
DK172670B1 (da) 1999-05-10
JP2554611B2 (ja) 1996-11-13
EP0060129A3 (en) 1983-06-01
NZ199866A (en) 1984-11-09
WO1982003088A1 (en) 1982-09-16
DK101982A (da) 1982-09-10

Similar Documents

Publication Publication Date Title
ATE47961T1 (de) Impfstoffe, verfahren zu deren herstellung und verfahren zur anregung der antikoerperherstellung.
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
DE69022290D1 (de) Lebende Impfstoffe.
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
ATE44765T1 (de) Lebend-impfstoff und verfahren zu dessen herstellung.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
FI860015L (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
AU1915995A (en) Active immunization using a siderophore receptor protein
BR8807376A (pt) Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuado
ES462588A1 (es) Procedimiento para la obtencion de vacunas, por tratamiento de microorganismos en un campo electrico de corriente alter-na.
DE59006080D1 (de) Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum.
ATE307605T1 (de) Nichttoxische mutanten pathogener gram-negativer bakterien
BR8203507A (pt) Polipeptideo sequencia de dna veiculo de expressao microbiana replicavel plasmideo microorganismo cultura microbiana uso de um polipeptideo vacina e processo para producao de um polipeptideo
AU7763294A (en) Live in ovo vaccine
DE69322092D1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
BE857014R (fr) Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.
CA2231332A1 (en) Bacterial delivery system
FI102189B1 (fi) Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämiseksi
ATE62270T1 (de) Herstellung des e.coli-lt-benterotoxinunterteils.
GB1413614A (en) Virus production
ATE43139T1 (de) Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.
ATE31733T1 (de) Verfahren zur herstellung von hybridisierungssonden.
DE3887635D1 (de) Verfahren zur Herstellung von Produkten von Fremdgenen.
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
FI885023L (fi) Menetelmä Plasmodium falciparum SGE2 -kannan HRPII-antigeenin ja tätä antigeeniä sisältävän malariarokotteen valmistamiseksi, HRPII-antigeeniä koodaava DNA- ja RNA-sekvenssi ja tätä DNA:ta sisältävä vektori ja bakteerisolu

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time